Cargando…

The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis

OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) is associated with kidney diseases and is used as a prognostic factor of renal function progression. The aim of this study was to explore whether circulating suPAR was associated with antineutrophil cytoplasmic autoantibody- (AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Fei, Li, Yueqiang, Xu, Ranran, Cheng, Anying, Lv, Yongman, Liu, Qingquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166284/
https://www.ncbi.nlm.nih.gov/pubmed/32322165
http://dx.doi.org/10.1155/2020/7850179
_version_ 1783523528361902080
author Huang, Fei
Li, Yueqiang
Xu, Ranran
Cheng, Anying
Lv, Yongman
Liu, Qingquan
author_facet Huang, Fei
Li, Yueqiang
Xu, Ranran
Cheng, Anying
Lv, Yongman
Liu, Qingquan
author_sort Huang, Fei
collection PubMed
description OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) is associated with kidney diseases and is used as a prognostic factor of renal function progression. The aim of this study was to explore whether circulating suPAR was associated with antineutrophil cytoplasmic autoantibody- (ANCA-) associated vasculitis (AAV) disease activity. METHODS: We evaluated 90 AAV patients with follow-up data and 35 normal controls; their plasma suPAR and C-reactive protein (CRP) levels were measured by ELISA. Associations between these levels, clinical parameters, and prognosis were analyzed. RESULTS: Plasma suPAR levels in AAV patients were significantly higher than in healthy controls (5,920.08 ± 3,447.17 vs. 1,441.97 ± 835.04 pg/mL, P < 0.001). Furthermore, suPAR was significantly elevated in AAV patients in active stage compared to those in partial remissions (6,492.19 ± 3,689.48 vs. 5,031.86 ± 2,489.01 pg/mL, P = 0.039). Correlation analyses demonstrated that suPAR levels positively correlated with initial serum creatinine, BVAS, CRP, and procalcitonin concentration, and negatively correlated with eGFR and C3 circulating levels. In a Kaplan-Meier survival analysis, patients with plasma suPAR levels >5683.3 pg/mL showed poorer survival than patients with lower levels (log-rank, P = 0.001). Besides, multivariate analyses confirmed that plasma suPAR levels were an independent adverse prognostic factor for a composite outcome of end-stage renal disease (ESRD) or death, after adjusting for age and gender (HR 1.05, 95% CI = 1.01 − 1.11, P = 0.043). Receiver operating characteristic curves showed a suPAR cutoff value >6662.2 pg/mL for composite outcome with 68% sensitivity and 88% specificity, with an AUC = 0.82, (95% CI = 0.68 − 0.96, P < 0.001). CONCLUSION: Circulating suPAR levels might be a marker of activity correlated with disease activity in AAV patients, and, to some extent, could be a factor of poor prognosis.
format Online
Article
Text
id pubmed-7166284
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-71662842020-04-22 The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis Huang, Fei Li, Yueqiang Xu, Ranran Cheng, Anying Lv, Yongman Liu, Qingquan Mediators Inflamm Research Article OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) is associated with kidney diseases and is used as a prognostic factor of renal function progression. The aim of this study was to explore whether circulating suPAR was associated with antineutrophil cytoplasmic autoantibody- (ANCA-) associated vasculitis (AAV) disease activity. METHODS: We evaluated 90 AAV patients with follow-up data and 35 normal controls; their plasma suPAR and C-reactive protein (CRP) levels were measured by ELISA. Associations between these levels, clinical parameters, and prognosis were analyzed. RESULTS: Plasma suPAR levels in AAV patients were significantly higher than in healthy controls (5,920.08 ± 3,447.17 vs. 1,441.97 ± 835.04 pg/mL, P < 0.001). Furthermore, suPAR was significantly elevated in AAV patients in active stage compared to those in partial remissions (6,492.19 ± 3,689.48 vs. 5,031.86 ± 2,489.01 pg/mL, P = 0.039). Correlation analyses demonstrated that suPAR levels positively correlated with initial serum creatinine, BVAS, CRP, and procalcitonin concentration, and negatively correlated with eGFR and C3 circulating levels. In a Kaplan-Meier survival analysis, patients with plasma suPAR levels >5683.3 pg/mL showed poorer survival than patients with lower levels (log-rank, P = 0.001). Besides, multivariate analyses confirmed that plasma suPAR levels were an independent adverse prognostic factor for a composite outcome of end-stage renal disease (ESRD) or death, after adjusting for age and gender (HR 1.05, 95% CI = 1.01 − 1.11, P = 0.043). Receiver operating characteristic curves showed a suPAR cutoff value >6662.2 pg/mL for composite outcome with 68% sensitivity and 88% specificity, with an AUC = 0.82, (95% CI = 0.68 − 0.96, P < 0.001). CONCLUSION: Circulating suPAR levels might be a marker of activity correlated with disease activity in AAV patients, and, to some extent, could be a factor of poor prognosis. Hindawi 2020-04-07 /pmc/articles/PMC7166284/ /pubmed/32322165 http://dx.doi.org/10.1155/2020/7850179 Text en Copyright © 2020 Fei Huang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Huang, Fei
Li, Yueqiang
Xu, Ranran
Cheng, Anying
Lv, Yongman
Liu, Qingquan
The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
title The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
title_full The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
title_fullStr The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
title_full_unstemmed The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
title_short The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis
title_sort plasma soluble urokinase plasminogen activator receptor is related to disease activity of patients with anca-associated vasculitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166284/
https://www.ncbi.nlm.nih.gov/pubmed/32322165
http://dx.doi.org/10.1155/2020/7850179
work_keys_str_mv AT huangfei theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT liyueqiang theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT xuranran theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT chenganying theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT lvyongman theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT liuqingquan theplasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT huangfei plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT liyueqiang plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT xuranran plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT chenganying plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT lvyongman plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis
AT liuqingquan plasmasolubleurokinaseplasminogenactivatorreceptorisrelatedtodiseaseactivityofpatientswithancaassociatedvasculitis